Aethlon Medical (AEMD) Common Equity (2016 - 2024)
Historic Common Equity for Aethlon Medical (AEMD) over the last 14 years, with Q4 2024 value amounting to $4.3 million.
- Aethlon Medical's Common Equity fell 4305.58% to $4.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.3 million, marking a year-over-year decrease of 4305.58%. This contributed to the annual value of $5.8 million for FY2024, which is 6172.16% down from last year.
- According to the latest figures from Q4 2024, Aethlon Medical's Common Equity is $4.3 million, which was down 4305.58% from $6.0 million recorded in Q3 2024.
- In the past 5 years, Aethlon Medical's Common Equity ranged from a high of $24.7 million in Q2 2021 and a low of $4.3 million during Q4 2024
- Over the past 5 years, Aethlon Medical's median Common Equity value was $13.3 million (recorded in 2020), while the average stood at $13.3 million.
- Its Common Equity has fluctuated over the past 5 years, first surged by 6552804.76% in 2020, then crashed by 6172.16% in 2024.
- Quarter analysis of 5 years shows Aethlon Medical's Common Equity stood at $11.4 million in 2020, then skyrocketed by 79.81% to $20.6 million in 2021, then dropped by 15.95% to $17.3 million in 2022, then tumbled by 55.95% to $7.6 million in 2023, then tumbled by 43.06% to $4.3 million in 2024.
- Its Common Equity was $4.3 million in Q4 2024, compared to $6.0 million in Q3 2024 and $8.7 million in Q2 2024.